Modular retro-vectors for transgenic and therapeutic use

Molecular Reproduction and Development

Volumn 56, Issue 2 SUPPL., 2000, Pages 309-315

  Solaiman, Fauzia ^a,b   Zink, Mary Ann ^a,b   Xu, Guoping ^a   Grunkemeyer, James ^b,c   Cosgrove, Dominic ^b,c   Saenz, Jennifer ^a   Hodgson, Clague P ^a,b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATURE TECHNOLOGY CORPORATION   (United States)

^c BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONING VECTOR; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; LONG TERMINAL REPEAT; PRIORITY JOURNAL; RETROVIRUS; TRANSCRIPTION REGULATION; TRANSGENE; TRANSGENIC ANIMAL;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034066055     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2795(200006)56:2+<309::aid-mrd22>3.0.co;2-y     Document Type: Conference Paper

References (49)

1. Armentano DD, Yu S-F, Kantoff PW. 1987. Effect of internal viral sequences on the utility of retroviral vectors. J Virol 61:1639-1646.
2. Barber JR, Jolly DJ, Respess JG, Chang SMW. 1997. Retroviral packaging cell lines. US Patent 5,591,624.
3. Barklis E, Mulligan RC, Jaenisch R. 1986. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399.
4. Bender MA, Palmer TD, Gelinas RE, 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol 61:1639-1646.
5. Burns JC, Yee J-K, Friedmann T. 1996. Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors. US Patent 5,512,421.
6. Carter AT, Norton JD, Avery RJ. 1983. A novel approach to cloning transcriptionally active retrovirus-like genetic elements from mouse cells. Nucleic Acids Res 18:6243-6254.
7. Chakraborty AK, Zink MA, Boman BM, Hodgson CP. 1993. Synthetic retrotransposon vectors for gene therapy. FASEB J 7:971-977.
8. Cook RF, Cook SJ, Hodgson CP. 1991. Retrotransposon gene engineering. Bio/Technology 9:748-751.
9. Cosset F-L, Takeuchi Y, Battini J-L, Weiss RA, Collins MKL. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69:7430-7436.
10. Feng M, Jackson WH, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G, Curiel DT. 1997. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol 15:866-870.
11. Finer MH, Dull TR, Qin L, Farson D, Roberts MR. 1994. kat: a high efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43-50.
12. Galili U, Shohet SB, Kobrin E, Stults CLM, Macher BA. 1988. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactoxyl epitopes on nucleated cells. J Biol Chem 263:17755-17762.
13. Grunkemeyer J. 1999. Characterization of VL30-derived vector expression in vitro and in vivo. Ph.D. Dissertation, Creighton University.
14. Harbers K, Schnieke A, Stuhlmann H, Jahner D, Jaenisch R. 1981. DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning. Proc Natl Acad Sci USA 78:7609-7613.
15. Hodgson CP, Solaiman F. 1996. Virosomes: cationic liposomes enhance retroviral transduction. Nature Biotechnol 14:339-342.
16. Hodgson CP, Xu G, Zink MA. 1998. Self-assembling genes, vectors and uses thereof. World Intellectual Property Organization (WIPO) Patent Publication no. WO 98/38326.
17. Hodgson CP, Solaiman F, Zink MA, Hodgson KL, Xu G 1998. Semi-synthetic systems for gene delivery. In: Kabanov AV, Felgner PL, Seymour LW, editors. Self-assembling complexes for gene delivery. New York: John Wiley & Sons. p 373-385.
18. Hodgson CP, Xu G, Solaiman F, Zink MA. 1997. Progress toward synthetic retro-vectoring systems for gene therapy. J Mol Med 75:249-258.
19. Hodgson CP, Xu G, Zink MA. 1999. Chimeric retro-vector without gag gene sequences. World Intellectual Property Organization (WIPO) Patent Publication no. WO 99/25862.
20. Jaenisch R. 1976. Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc Natl Acad Sci USA 73:1260-1264.
21. Kochanek S, Clemens PR, Mitani K, Chen H-H, Chan S, Caskey CT. 1996. A new adenoviral vector: replacement of all viral coding sequences with 38 kb of DNA independently expressing both full-length dystrophin and (β)-galactosidase. Proc Natl Acad Sci USA 93:5731-5736.
22. Lebedenko EN, Birikh KR, Blutalov OV, Berlin YA. 1991. Method of artificial DNA splicing by directed ligation (SDL). Nucleic Acids Res 19:6757-5761.
23. Mandecki W, Bolling JT. 1988. Fok1 method of gene synthesis. Gene 68:101-107.
24. Markowitz D, Goff S, Bank A. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virol 167:400-406.
25. Markowitz D, Goff S, Bank A. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 62:1120-1124.
26. Miller AD, Buttimore C. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895-2902.
27. Miller AD, Garcia JV, von Suhr N. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220-2224.
28. Miller AD, Rosman GJ. 1989. Improved retroviral vectors for gene transfer and expression. Bio/Techniques 7:980-987.
29. Moses PB, Horiuchi K. 1979. Specific recombination in vitro promoted by restriction endonuclease Hga1. J Mol Biol 135:517-524.
30. 3 subgroups correlate with their enhancer design. J Virol 68:276-288.
31. Norton JD, Hogan BLM. 1988. Temporal and tissue-specific expression of distinct retrovirus-like (VL30) elements during mouse development. Dev Biol 125:226-228.
32. Otto E, Jones-Trower A, Vanin EF. 1994. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 5:567-575.
33. Pensiero MN, Wysocki CA, Nader K, Kikuchi GE. 1996. Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Hum Gene Ther 7:1095-1101.
34. Porter CD, Lukacs KV, Box G, Takeuchi Y, Collins MKL. 1998. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol 72:4832-4840.
35. Price J, Turner D, Cepko C. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 84:156-160.
36. Qiu C, de Young MB, Finn A, Dichek DA. 1998. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and α-integrins. Hum Gene Ther 9:507-520.
37. Rasheed W, Gardner MB, Chan E. Amphotropic host range of naturally occurring wild mouse leukemia viruses. J Virol 19:13-18.
38. Robertson E, Bradley A, Kuehn M, Evans M. 1986. Germ-line transmission of genes introduced into cultured pluripotent cells by retroviral vector. Nature 323:445-448.
39. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ropnaghy A, Kornbluth RS, Richmann DD, Carson DA, Raz E. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:829-831.
40. Sato Y, Roman M, Tighe H, Lee D, Corr M, Mguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
41. Scadden ET, Fuller B, Cunningham JM. 1990. Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J Virol 64:424-427.
42. Sciamanna I, Piccoli S, Barberi L, Zaccagnini C, Magnano AR, Giordano R, Campedelli P, Hodgson C, Lorenzini R, Spadafora C. 2000. DNA dose and sequence of dependence in sperm-mediated gene transfer. Mol Reprod Dev 56:301-308.
43. Stuhlmann H, Jahner E, Jaenisch. 1981. Infectivity and methylation of retroviral genomes is correlated with expression in the animal. Cell 26:221-229.
44. Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, Cosset F-L, Weiss RA, Collins MKL. 1996. Sensitization of cells and retroviruses to human serum by α(1-3)galactosyltransferase. Nature 379:85-88.
45. Tang MX, Redemann CT, Szoka FC. 1996. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem 7:703-714.
46. Themis M, Forbes SJ, Chan L, Cooper RG, Etheridge CJ, Miller AD, Hodgson HJF, Coutelle C. 1998. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors. Gene Ther 5:1180-1186.
47. Tomic M, Sunjevaric I, Savtchenko ES, Blumenberg M. 1990. A rapid and simple method for introducing specific mutations into any position of DNA leaving all other positions unaltered. Nucleic Acids Res 18:1656.
48. Urdea MS, Merryweather JP, Mullenback GT, Coit D, Heberlein U, Valenzuela P, Barr PJ. 1983. Chemical synthesis of a gene for human epidermal growth factor uragastrone and its expression in yeast. Proc Natl Acad Sci USA 80:7461-7465.
49. Xu G, Solaiman F, Zink MA, Hodgson CP. 1999. Fusogenic effect of murine retroviruses and cationic enhancers of transduction. Cancer Gene Ther 7:53-58.